TokyoMay 20, 2026 /PRNewswire/ — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, hereinafter “Eisai”) recently announced that it has been selected for the first time as one of the “SX Brands 2026,” jointly recognized by Japan’s Ministry of Economy, Trade and Industry (METI) and the Tokyo Stock Exchange (TSE).
SX (Sustainability Transformation) is an initiative that treats medium- to long-term risks and business opportunities arising from social sustainability challenges as key management issues, and promotes management and business transformation oriented toward sustainable growth through constructive dialogue with stakeholders such as investors. SX Brands refer to a group of advanced companies that continuously enhance their ability to create growth resources through SX, thereby increasing corporate value. This designation is jointly selected and announced by METI and the TSE. The mechanism was launched in 2024, and this year’s “SX Brands 2026” marks the third edition, with 15 companies selected.
Eisai was recognized for its commitment to maximizing its intrinsic corporate value over the medium to long term. Based on its corporate philosophy, Eisai defines this value as the sum of “social impact*” and “financial value” generated by addressing social issues such as dementia, cancer, and global health. Reasons for selection include: incorporating ecosystem-building initiatives into Eisai’s business model through collaboration with companies and local governments, aiming to provide both pharmaceutical and non-pharmaceutical solutions across various life stages, from daily life to medical care. Additionally, constructive communication with investors based on clear medium-term plans and key performance indicators, as well as the implementation of highly transparent capital policies, were highly evaluated by the market and contributed to the selection.
Eisai’s corporate philosophy is to prioritize the joys and sorrows of patients and people in daily life, and to contribute to improving their well-being. Guided by the “hhc” (human health care) concept, we aim to effectively achieve social well-being in the form of alleviating health anxieties and reducing healthcare disparities. By further enhancing sustainability and realizing social well-being, Eisai will continue to increase corporate value and strive to make greater contributions to the well-being of patients and people in daily life.
*: Refers to the numerical value calculated by monetizing Eisai’s intrinsic corporate value (i.e., various positive impacts on society) that is not reflected in sales revenue or profits.